STAT+: In early trial, CAR-T results raise hope of preventing multiple myeloma in high-risk patients
A CAR-T trial shows promise in preventing smoldering multiple myeloma from becoming the real thing.
A CAR-T trial shows promise in preventing smoldering multiple myeloma from becoming the real thing.
An authoritative look at current FDA-approved weight loss medications, their brands and results, and how obesity intersects with disability
The Breakthrough Prize winners, Trump's psychedelics executive order, and more biotech news from The Readout
And more pharma news from the Pharmalot campus via the Pharmalittle newsletter
Pharma industry middlemen are pushing back on a major drug price transparency proposal.
A leading animal rights group is accusing Pfizer of running afoul of its own standards in the handling of research monkeys.
Peter Stetson is the CMIO of TigerConnect. It’s now calling itself an AI platform to connect people, especially workflows between doctors, nurses, EMTs and devices. Until recently he was CMIO…
In full transparency, I’ve been a fangirl of Kara Swisher since I first read her work with Walt Mossberg and Recode, coinciding with my own work on the early adoption…
New USC research finds non-smoking adults under 50 who eat more fruits, vegetables and whole grains may face a higher risk of early-onset lung cancer
Daraxonrasib, a pancreatic cancer drug from Revolution Medicines, is showing unprecedented success. For patients like Leanna Stokes, survival time doubled.